Preclinical News and Research

RSS
Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs

Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs

Profibrix raises funds for clinical and preclinical development

Profibrix raises funds for clinical and preclinical development

NovaBay Pharmaceuticals to deliver two poster presentations describing results from new studies of NVC-422

NovaBay Pharmaceuticals to deliver two poster presentations describing results from new studies of NVC-422

Mount Sinai Medical Center physicians pioneer a non-surgical procedure for treating LAA

Mount Sinai Medical Center physicians pioneer a non-surgical procedure for treating LAA

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Ron Demuth of ChemDiv announces extension of collaboration with Lilly

Ron Demuth of ChemDiv announces extension of collaboration with Lilly

Southern Research's Birmingham campus to have a Comprehensive Chemical Biology Center

Southern Research's Birmingham campus to have a Comprehensive Chemical Biology Center

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Institutional investor buys $30 million of convertible stock and warrants in Cell Therapeutics

Institutional investor buys $30 million of convertible stock and warrants in Cell Therapeutics

Scientists develop new technique to target brain cancer cells

Scientists develop new technique to target brain cancer cells

Nano-bio material kills cancer cells, leaves healthy cells in unharmed

Nano-bio material kills cancer cells, leaves healthy cells in unharmed

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Custom-tailored anti-cancer drugs

Custom-tailored anti-cancer drugs

Algos Therapeutics changes name to Algos Preclinical Services

Algos Therapeutics changes name to Algos Preclinical Services

George Rehm and David Mahoney joins Adamas' Board of Directors

George Rehm and David Mahoney joins Adamas' Board of Directors

4SC starts phase 2 trial in hepatocellular carcinoma with 4SC-201 (resminostat)

4SC starts phase 2 trial in hepatocellular carcinoma with 4SC-201 (resminostat)

Inhibitex reports Q2 2009 financials

Inhibitex reports Q2 2009 financials

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

Seattle Genetics reaches milestone under collaboration agreement with MedImmune

Seattle Genetics reaches milestone under collaboration agreement with MedImmune

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.